Legionella Pneumophila Antikörper (Serogroup 4)

Produktnummer ABIN110853

Der Maus Monoklonal anti-Legionella Pneumophila Antikörper (Klon LP101) (ABIN110853) detektiert spezifisch Legionella Pneumophila in IF. Dieser Antikörper reagiert spezifisch mit Proben aus Legionella pneumophila.

Kurzübersicht für Legionella Pneumophila Antikörper (Serogroup 4) (ABIN110853)

Target: Legionella Pneumophila

Reaktivität: Legionella pneumophila

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser Legionella Pneumophila Antikörper ist unkonjugiert

Applikation: Immunofluorescence (IF)

Klon: LP101

Produktdetails anti-Legionella Pneumophila Antikörper

Bindungsspezifität: Serogroup 4

Aufreinigung: Affinity Chromatography on Protein G

Immunogen: Legionella pneumophila serogroups 4,10,14.

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Immunofluorescence.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Konzentration: 1.0 mg/mL

Buffer: PBS, 0.09 % Sodium Azide

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Avoid repeated freezing and thawing.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.

Details zu Legionella Pneumophila

Target: Legionella Pneumophila

Substanzklasse: Bacteria

Hintergrund: Legionella pneumophila is a flagellated gram negative bacterium found primarily in warm water environments. Legionella pneumophila causes a type of pneumonia called Legionnaire disease and a milder condition called Pontiac fever. Infection is acquired through inhalation of the microorganism in water mists (e.g. from air conditioning, cooling towers, whirlpool spas and showers mists). A number of risk factors for acquiring Legionnaire disease have been identified, including age, smoking, chronic lung disease, cancer, and immunosuppression.